Tremfya denied by insurance? Appeal and win.
A Tremfya denial almost never means the drug is wrong for you, it usually means the plan wants its paperwork in a different order. Because guselkumab is a selective IL-23p19 blocker, payers routinely demand documented failure or intolerance of a TNF inhibitor and often a cheaper IL-17 agent first, or they question whether your plaque psoriasis truly meets the moderate-to-severe threshold versus mild disease they would rather treat topically. We win these by anchoring the file to the exact indication and ICD-10 (L40.0 for plaque psoriasis, L40.50 to L40.59 for psoriatic arthritis, or K51 for ulcerative colitis), pairing it with a body-surface-area and PASI or IGA score that crosses the severity line, and laying out the dated record of every prior systemic and biologic you actually tried and why it failed or harmed you. When the medical necessity is told as one clean, chronological story, the step-therapy wall stops being a reason to say no.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Plaque psoriasis and psoriatic arthritis.
Why Tremfya gets denied
- Biologic step-therapy requirement
- Prior-authorization criteria not documented
- Diagnosis or severity not evidenced
- Formulary placement
What a winning appeal includes
- Confirmed diagnosis with severity
- Prior therapies and outcomes
- Dermatology or rheumatology support
- A letter of medical necessity
How we approach the appeal
Document severity and prior-therapy failure, and request a step-therapy override mapped to plan criteria.
Tremfya appeal letter template
Copy this Tremfya appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns IL-23 biologic denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Tremfya denial I am appealing the denial of Tremfya (guselkumab). I request that the denial be overturned and Tremfya approved. 1. The denial. [Insurer] denied Tremfya stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Tremfya is medically necessary for my condition. Document severity and prior-therapy failure, and request a step-therapy override mapped to plan criteria. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Tremfya within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Tremfya denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
Why was Tremfya denied?
Most often a biologic step-therapy requirement or undocumented severity, both addressable on appeal.
Tremfya denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.